Vizgen accuses Harvard and 10x of patent licence cover-up

04-05-2023

Liz Hockley

Vizgen accuses Harvard and 10x of patent licence cover-up

Jon Bilous / Shutterstock.com

Firm says patents-in-suit were developed using $19 million of public money | Biotech also cites “new evidence” in suit with Harvard and 10x.


Harvard, Vizgen, patents, genomics, licence, Nanostring, biotech, FOIA, Delaware, patents-in-suit

LSIPR